Tamoxifen for Breast Cancer

Authors

  • A Karn Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur
  • A K Jha Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur
  • S Shrestha Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur
  • B Acharya Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur
  • S Poudel Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur
  • R B Bhandari Department of Radiation Oncology, BP Koirala Memorial Cancer Hospital, Bharatpur

DOI:

https://doi.org/10.31729/jnma.140

Abstract

Breast cancer is one of the common cancers. Hormonal therapy along with surgery, chemotherapy, radiotherapy and targeted therapy are vital modalities for the management of breast cancer. Tamoxifen has been the most widely used hormonal therapy for more than two decades. In this article we review the benefits, dose, duration and timing of Tamoxifen therapy in patients with breast cancer.

Keywords: breast cancer, hormonal therapy, tamoxifen.

Downloads

Published

2010-03-31

How to Cite

Karn, A., Jha, A. K., Shrestha, S., Acharya, B., Poudel, S., & Bhandari, R. B. (2010). Tamoxifen for Breast Cancer. Journal of Nepal Medical Association, 49(177). https://doi.org/10.31729/jnma.140

Issue

Vol. 49 No. 177 (2010)

Section

Review Article

License

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.

Most read articles by the same author(s)

1 2 3 > >>